Maaike E. Schutte

Flavonoids and alkenylbenzenes: mechanisms of mutagenic action and carcinogenic risk.

Ivonne M C M Rietjens, G. Alink, I. Rietjens, 2005, Mutation research.

An in vitro and in silico study on the flavonoid-mediated modulation of the transport of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) through Caco-2 monolayers.

J. J. van de Sandt, J. Groten, G. Alink, 2006, Toxicology and applied pharmacology.

Effect of (mixtures of) flavonoids on the in vitro and in vivo bioavailability of 2-mino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) : a biologically based modelling approach

M. Schutte, Maaike E. Schutte, Effectof, 2007 .

Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients.

J. Groten, P. van Bladeren, G. Williamson, 2006, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Generation of primary hepatocyte microarrays by piezoelectric printing.

J. Cooper, M. Dawson, A. Glidle, 2012, Colloids and surfaces. B, Biointerfaces.

Quercetin increases the bioavailability of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rats.

J. J. van de Sandt, J. Groten, G. Alink, 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.